DeepDx® Prostate
| Solution Type | AI Suite/Add-on |
|---|---|
| Deployment Environment | Clinical Diagnostics |
| Regulatory Clearance | Prostate Cancer – CE-IVD, Prostate Cancer – South Korea IVD |
| Target | Prostate Cancer |
| Platform Dependency | Requires Specific Platform |
| Deployment Options | Hybrid (Cloud analysis, local viewer) |
Be the first to review “DeepDx® Prostate” Cancel reply
Have you considered:
Compare Solutions
No products to compare
Get Pathology News Delivered to Your Inbox
News
Editor2026-10-05T08:39:55+00:00
A Study Performed in the Microbiology Department of Vall d’Hebron University Hospital Shows High Agreement Between Manual Microscopy and Techcyte’s AI for Ova and Parasite Testing.
Editor2026-10-05T08:39:55+00:00October 5, 2026|
Editor2026-10-02T08:40:33+00:00
PathVisions2026 Workshop: How Leading Centers Are Building Connected Pathology Workflows with PathPresenter
Editor2026-10-02T08:40:33+00:00October 2, 2026|
Editor2026-10-05T13:14:14+00:00
Imagene AI and CellCarta Expand Collaboration to Validate, Deploy and Scale AI-Powered Biomarker and Companion Diagnostic Programs Across Drug Development
Editor2026-10-05T13:14:14+00:00October 2, 2026|
Editor2026-10-06T08:47:12+00:00
In Conversation with Nasir Rajpoot, TIA Centre (University of Warwick) – Episode 3
Editor2026-10-06T08:47:12+00:00October 1, 2026|
Editor2026-10-06T09:05:52+00:00
Aignostics Joins Techcyte Fusion® Partner Program to Bring PathoSearch to Fusion AP
Editor2026-10-06T09:05:52+00:00October 1, 2026|
Editor2026-10-01T08:24:33+00:00
Innovators at the Table: The Right Treatment for the Right Patient – Podcast
Editor2026-10-01T08:24:33+00:00October 1, 2026|
Editor2026-09-29T12:52:02+00:00
Techcyte Receives 2026 Innovation Award from Sonora Quest Laboratories
Editor2026-09-29T12:52:02+00:00September 29, 2026|
















Reviews
There are no reviews yet.